NCT00252226View on ClinicalTrials.gov

Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Bipolar Disorder

Interventions

DRUG

Quetiapine

Trial Locations (1)

K1G 4G3

Mood Disorders Center of Ottawa, Ottawa

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Mood Disorders Center of Ottawa

OTHER